On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database FSH de Souza, NS Hojo-Souza, BDO Batista, CM da Silva, DL Guidoni PloS one 16 (3), e0248580, 2021 | 121 | 2021 |
Daily rhythms of TNFα expression and food intake regulate synchrony of plasmodium stages with the host circadian cycle IC Hirako, PA Assis, NS Hojo-Souza, G Reed, H Nakaya, DT Golenbock, ... Cell host & microbe 23 (6), 796-808. e6, 2018 | 79 | 2018 |
Predicting the disease outcome in COVID-19 positive patients through Machine Learning: a retrospective cohort study with Brazilian data FSH De Souza, NS Hojo-Souza, EB Dos Santos, CM Da Silva, ... Frontiers in Artificial Intelligence 4, 579931, 2021 | 75 | 2021 |
Second wave of COVID-19 in Brazil: younger at higher risk FSH de Souza, NS Hojo-Souza, CM da Silva, DL Guidoni European journal of epidemiology 36, 441-443, 2021 | 66 | 2021 |
On the cytokine/chemokine network during Plasmodium vivax malaria: new insights to understand the disease NS Hojo-Souza, DB Pereira, FSH de Souza, TA de Oliveira Mendes, ... Malaria journal 16, 1-10, 2017 | 40 | 2017 |
Pteridium aquilinum: o que sabemos eo que ainda falta saber NS Hojo-Souza, CM Carneiro, RC Santos Bioscience Journal 26 (5), 798-808, 2010 | 23 | 2010 |
Profile of Brazilian inpatients with COVID-19 vaccine breakthrough infection and risk factors for unfavorable outcome MAS de Jesus, NS Hojo-Souza, TR de Moraes, DL Guidoni, ... Revista panamericana de salud publica 46, e106, 2023 | 20 | 2023 |
Contributions of IFN-γ and granulysin to the clearance of Plasmodium yoelii blood stage NS Hojo-Souza, PO de Azevedo, JT de Castro, A Teixeira-Carvalho, ... PLoS Pathogens 16 (9), e1008840, 2020 | 20 | 2020 |
CD4+ T cells apoptosis in Plasmodium vivax infection is mediated by activation of both intrinsic and extrinsic pathways NS Hojo-Souza, DB Pereira, TAO Mendes, LSA Passos, ... Malaria journal 14, 1-7, 2015 | 20 | 2015 |
Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein JT Castro, P Azevedo, MJ Fumagalli, NS Hojo-Souza, N Salazar, ... Nature communications 13 (1), 4831, 2022 | 17 | 2022 |
Phenotypic profiling of CD8+ T cells during Plasmodium vivax blood-stage infection NS Hojo-Souza, DB Pereira, LSA Passos, PH Gazzinelli-Guimarães, ... BMC Infectious Diseases 15, 1-9, 2015 | 14 | 2015 |
Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern PO Azevedo, NS Hojo-Souza, LP Faustino, MJ Fumagalli, IC Hirako, ... npj Vaccines 8 (1), 15, 2023 | 9 | 2023 |
An overview of Brazilian working age adults vulnerability to COVID-19 FSH de Souza, NS Hojo-Souza, DCR de Oliveira, CM Silva, DL Guidoni Scientific Reports 12 (1), 2798, 2022 | 9 | 2022 |
Uptake of Plasmodium chabaudi hemozoin drives Kupffer cell death and fuels superinfections IC Hirako, MM Antunes, RM Rezende, NS Hojo-Souza, MM Figueiredo, ... Scientific Reports 12 (1), 19805, 2022 | 8 | 2022 |
A temporal study of Brazilian pregnant and postpartum women vulnerability for COVID-19: Characteristics, risk factors and outcomes NS Hojo-Souza, DL Guidoni, CM Da Silva, FSH De Souza The Lancet Regional Health–Americas 9, 2022 | 8 | 2022 |
Pteridium aquilinum: what we know and what is yet to be learnt. NS Hojo-Souza, CM Carneiro, RC Santos | 8 | 2010 |
Protective Immunity against Gamma and Zeta Variants after Inactivated SARS-CoV-2 Virus Immunization MJ Fumagalli, LA Castro-Jorge, TFC Fraga-Silva, PO de Azevedo, ... Viruses 13 (12), 2440, 2021 | 7 | 2021 |
ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas’ disease JT Castro, R Brito, NS Hojo-Souza, B Azevedo, N Salazar, CP Ferreira, ... npj Vaccines 8 (1), 81, 2023 | 6 | 2023 |
Clinical symptom profile of hospitalized COVID-19 Brazilian patients according to SARS-CoV-2 variants NS Hojo-Souza, DL Guidoni, FSH de Souza Epidemiology and Health 45, 2023 | 5 | 2023 |
The immune response in Chagas disease and its role in the variability of clinical expression D Walderez, NS Hojo-Souza, KJ Gollob Revista Española de Salud Pública, 25-32, 2013 | 3 | 2013 |